These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24605725)

  • 21. Prevention of hypoglycaemia, the ASAP (Anticipate, Suspect, Act, Prevent) strategy.
    Kalra S; Gupta Y
    J Pak Med Assoc; 2017 Apr; 67(4):648-649. PubMed ID: 28420935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progress in therapy for diabetes mellitus--intensified insulin therapy].
    Yamada K
    Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):750-5. PubMed ID: 19472526
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hypoglycemia in patients treated with an external insulin pump].
    Laurent JC; Waeber G; Ruiz J; Carron PN
    Rev Med Suisse; 2011 Jan; 7(278):166-9. PubMed ID: 21400952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin pump therapy and rapid acting insulin: what have we learned?
    Zinman B
    Int J Clin Pract Suppl; 2001 Sep; (123):47-50. PubMed ID: 11594299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC; Sutton AJ
    Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Avoiding hypoglycaemia while achieving good glycaemic control in type 2 diabetes through optimal use of oral agent therapy.
    Barnett AH
    Curr Med Res Opin; 2010 Jun; 26(6):1333-42. PubMed ID: 20370379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment strategy for elderly diabetic patient with insulin or GLP-1 receptor agonist].
    Ando Y
    Nihon Rinsho; 2013 Nov; 71(11):1993-8. PubMed ID: 24397172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Advances in Nanotechnology-Based Diagnosis and Treatments of Diabetes.
    Rao PV; Gan SH
    Curr Drug Metab; 2015; 16(5):371-5. PubMed ID: 25429672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Siebenhofer A; Jeitler K; Berghold A; Horvath K; Pieber TR
    Diabet Med; 2009 Mar; 26(3):311-2; author reply 312-3. PubMed ID: 19317829
    [No Abstract]   [Full Text] [Related]  

  • 31. Understanding insulins: new developments.
    Robertson D
    Br J Hosp Med (Lond); 2008 Jan; 69(1):M2-5. PubMed ID: 18293725
    [No Abstract]   [Full Text] [Related]  

  • 32. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of responses to acute hypoglycaemia induced by human and porcine insulins in patients with Type 1 diabetes.
    MacLeod KM; Gold AE; Frier BM
    Diabet Med; 1996 Apr; 13(4):346-57. PubMed ID: 9162611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unlocking the opportunity of tight glycaemic control. Innovative delivery of insulin via the lung.
    Patton JS
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S5-8. PubMed ID: 16135136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New trends in therapy of diabetes. More freedom, fewer risks, comfortable insulin administration].
    Harsch IA; Hahn EG; Ficker JH
    MMW Fortschr Med; 2000 Jul; 142(28-29):24-6. PubMed ID: 10959155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycaemic control in south Asian patients during feasting and fasting.
    Asghar O; Greenstein A; Malik RA
    Br J Hosp Med (Lond); 2006 Oct; 67(10):523-6. PubMed ID: 17069121
    [No Abstract]   [Full Text] [Related]  

  • 37. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.
    Liebl A; Hoogma R; Renard E; Geelhoed-Duijvestijn PH; Klein E; Diglas J; Kessler L; Melki V; Diem P; Brun JM; Schaepelynck-Bélicar P; Frei T;
    Diabetes Obes Metab; 2009 Nov; 11(11):1001-8. PubMed ID: 19740082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The need for better insulin therapy.
    Grunberger G
    Diabetes Obes Metab; 2013 Mar; 15 Suppl 1():1-5. PubMed ID: 23448196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
    Valensi P; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Wenying Y;
    Int J Clin Pract; 2009 Mar; 63(3):522-31. PubMed ID: 19187170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of insulin development: focus on key parameters.
    Tibaldi JM
    Adv Ther; 2012 Jul; 29(7):590-619. PubMed ID: 22843207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.